Sign in
Taking people in United StatesNo phase

Tests a phone-based weight program for young adult cancer survivors with excess weight

Tests a phone-based weight program in adults aged 18 to 39 who had cancer.

Key facts

Who runs it
UNC Lineberger Comprehensive Cancer Center
Where
Chapel Hill, United StatesSee the site
Trial code
Registry title
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Status
Recruiting
People taking part
240 people, planned
Started
27 Oct 2025
Expected to end
31 Oct 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • AYA WELL Intervention
  • Self-Guided
Record updated
24 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young adult cancer survivors aged 18-39 who are done with cancer treatment and have overweight or obesity. It tests a phone-based weight management program.

Age
18-39 years old at the time of consent. First invasive cancer diagnosed between ages 15-39.
Sex
All sexes can join.
Disease stage
Within 10 years of the cancer diagnosis, with no sign of progressing disease or a second primary cancer (self-reported). Body mass index (BMI) of 25-50 kg/m2.
Earlier treatment
Active cancer treatment (chemotherapy, radiation and/or definitive surgery) finished at least six months before joining. Maintenance therapy to prevent recurrence is allowed.

Main reasons for not taking part

  • Type 1 diabetes, or certain treatments for Type 2 diabetes
  • Heart attack or stroke in the last 6 months
  • Lost 5% or more of body weight in the last 3 months
  • Eating disorder history, or currently pregnant, pregnant in the past 6 months or planning pregnancy in the next 12 months
  • Not living in the United States, no mobile phone with data plan or internet access, or cannot speak and read English

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • 18-39 years old at the time of consent
  • Diagnosed with first invasive cancer between ages 15-39 years (self-report)
  • Within 10 years of diagnosis with no evidence of progressive disease or second primary cancers (self-report)
  • Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) at least six months prior to enrollment; may be receiving "maintenance" therapy to prevent recurrences (self-report)
  • Body mass index (BMI) of 25-50 kg/m2

Who cannot take part

  • Type 1 diabetes or currently receiving certain medical treatments for Type 2 diabetes
  • Report a history of heart attack or stroke within previous 6 months
  • Lifetime history of clinical diagnosis or treatment of eating disorder (anorexia nervosa or bulimia nervosa), OR report of compensatory behaviors within the previous 3 months. If participant reports a history of compensatory behaviors, the investigators will review their information to determine eligibility
  • Currently using prescription medications with known effects on appetite or weight (e.g., oral steroids, weight loss medications), with the exception of individuals on a stable dose of SSRIs for 3 months)
  • Previous surgical procedure for weight loss or planned weight loss surgery in the next year
  • Plans for major surgery (e.g., breast reconstruction) in the next 12 months
  • Health problems which preclude ability to walk for physical activity (e.g., lower limb amputation). Participants endorsing items 1-4 on the Physical Activity Readiness Questionnaire (PAR-Q) (experience of heart problems, frequent chest pains, or faintness or dizziness) will be excluded from the study
  • Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months
  • Hospitalization for depression or other psychiatric disorder within the past 12 months
  • History of psychotic disorder or uncontrolled bipolar disorder
  • Lost 5% or more of body weight (and kept it off) in the last 3 months
  • Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 12 months
  • Currently participating in a weight loss, nutrition, or physical activity study or program or other study that would interfere with this study
  • Inability to speak and read English
  • Does not reside in the United States
  • Do not have mobile phone with data plan or willing to be contacted by study through text messaging
  • No Internet access
  • Not willing to be randomized to either intervention arm

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 39 years old?

Where in United States

  • University of North Carolina at Chapel HillChapel Hill, United StatesContact: Karen Hatley E Research Project Manager, MPH, RD, LDNTaking people

About the trial

What the trial wants to find out

The AYA WELL study is a 2-arm randomized clinical trial to test the efficacy of a theory-based, mHealth weight management intervention adapted specifically for adolescent and young adult cancer survivors compared to a self-guided arm. Participants, diagnosed with cancer between ages 15-39, currently age 18-39, post-treatment at least 6 months, and who have overweight or obesity will be randomized to receive either: 1) a comprehensive mHealth weight management program (intervention) or 2) digital tools + health education + peer support (self-guided) over 12 months. Outcomes will be assessed at 3, 6, and 12 months.

The 2 groups in the trial

  • InterventionTreatment being tested

    Intervention participants will receive a theory-based mHealth intervention that includes personalized nutrition and physical activity goals, psychoeducation, and evidence-based behavioral skills training delivered via a mobile web app with active content during the first 6 months, provision of digital tools to facilitate self-monitoring (a smart scale and physical activity tracker), an individual video kick-off session, text messages, and access to a closed social networking group with moderated prompts from study staff to foster peer support. Participants are encouraged to log in to web app daily to interact with self-monitoring and behavioral guidance instruction, activities, and feedback.

    Treatment: AYA WELL Intervention

  • Self-GuidedExisting treatment, for comparison

    Self-guided participants will receive digital tools (a smart scale and activity tracker), an individual video kick-off session, quarterly informational newsletters, and a moderated but non-prompted (by study staff) closed social networking group to enable peer support.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors (AYA Well)
Plain-language title
Tests a phone-based weight program for young adult cancer survivors with excess weightGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06848491, who can take part
Record updated
24 August 2026